Literature DB >> 15353969

Cryptosporidiosis: an update in molecular epidemiology.

Lihua Xiao1, Una M Ryan.   

Abstract

PURPOSE OF REVIEW: Molecular tools have been developed to detect and differentiate Cryptosporidium at the species/genotype and subtype levels. These tools have been increasingly used in the characterization of the transmission of Cryptosporidium spp. This review addresses the most recent developments in molecular epidemiology of cryptosporidiosis. RECENT
FINDINGS: The recent development of subtyping tools has led to better understanding of the population genetics and transmission of Cryptosporidium in humans. The population structure of C. parvum and C. hominis is apparently more complicated than previously suggested, with the likely existence of both clonal and panmictic populations. Thus, the transmission of C. parvum (genotype II) in humans is shown to be different in different areas, with zoonotic transmission important in certain places and anthroponotic transmission in others. The use of molecular tools has also led to the identification of geographic and temporal differences in the transmission of C. parvum and C. hominis, and better appreciation of the public health importance of other Cryptosporidium species/genotypes and the frequency of infections with mixed genotypes or subtypes.
SUMMARY: Factors involved in the transmission of human cryptosporidiosis are difficult to examine using conventional methods. The use of molecular tools has been helpful in the assessment of the zoonotic potential of various Cryptosporidium spp. and sources of human infections, and has started to play a significant role in the characterization of transmission dynamic in endemic and epidemic areas.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15353969     DOI: 10.1097/00001432-200410000-00014

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  91 in total

1.  Molecular and spatial epidemiology of cryptosporidiosis in children in a semiurban community in South India.

Authors:  Sitara Swarna Rao Ajjampur; Beryl Primrose Gladstone; David Selvapandian; Jaya Prakash Muliyil; Honorine Ward; Gagandeep Kang
Journal:  J Clin Microbiol       Date:  2007-01-24       Impact factor: 5.948

2.  Cryptosporidium genotypes in wildlife from a new york watershed.

Authors:  Yaoyu Feng; Kerri A Alderisio; Wenli Yang; Lisa A Blancero; William G Kuhne; Christopher A Nadareski; Michael Reid; Lihua Xiao
Journal:  Appl Environ Microbiol       Date:  2007-08-24       Impact factor: 4.792

3.  Stable expression of Cryptosporidium parvum glycoprotein gp40/15 in Toxoplasma gondii.

Authors:  Roberta M O'Connor; Jane W Wanyiri; Boguslaw S Wojczyk; Kami Kim; Honorine Ward
Journal:  Mol Biochem Parasitol       Date:  2007-01-07       Impact factor: 1.759

4.  Novel Bumped Kinase Inhibitors Are Safe and Effective Therapeutics in the Calf Clinical Model for Cryptosporidiosis.

Authors:  Deborah A Schaefer; Dana P Betzer; Kylie D Smith; Zachary G Millman; Hannah C Michalski; Sarah E Menchaca; Jennifer A Zambriski; Kayode K Ojo; Matthew A Hulverson; Samuel L M Arnold; Kasey L Rivas; Rama S R Vidadala; Wenlin Huang; Lynn K Barrett; Dustin J Maly; Erkang Fan; Wesley C Van Voorhis; Michael W Riggs
Journal:  J Infect Dis       Date:  2016-10-17       Impact factor: 5.226

5.  Antibodies fused to innate immune molecules reduce initiation of Cryptosporidium parvum infection in mice.

Authors:  Michael Imboden; Michael W Riggs; Deborah A Schaefer; E Jane Homan; Robert D Bremel
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

6.  Multi-locus analysis of human infective Cryptosporidium species and subtypes using ten novel genetic loci.

Authors:  Maha Bouzid; Kevin M Tyler; Richard Christen; Rachel M Chalmers; Kristin Elwin; Paul R Hunter
Journal:  BMC Microbiol       Date:  2010-08-09       Impact factor: 3.605

7.  Improved risk analysis by dual direct detection of total and infectious Cryptosporidium oocysts on cell culture in combination with immunofluorescence assay.

Authors:  Cindy Lalancette; George D Di Giovanni; Michèle Prévost
Journal:  Appl Environ Microbiol       Date:  2009-11-20       Impact factor: 4.792

8.  Cryptosporidium species and subtypes and clinical manifestations in children, Peru.

Authors:  Vitaliano A Cama; Caryn Bern; Jacqueline Roberts; Lilia Cabrera; Charles R Sterling; Ynes Ortega; Robert H Gilman; Lihua Xiao
Journal:  Emerg Infect Dis       Date:  2008-10       Impact factor: 6.883

9.  The population structure of the Cryptosporidium parvum population in Scotland: a complex picture.

Authors:  Liam J Morrison; Marianne E Mallon; Huw V Smith; Annette MacLeod; Lihua Xiao; Andy Tait
Journal:  Infect Genet Evol       Date:  2007-11-09       Impact factor: 3.342

10.  Cryptosporidium hominis infection of the human respiratory tract.

Authors:  Rubén Mercado; Gregory A Buck; Patricio A Manque; Luiz Shozo Ozaki
Journal:  Emerg Infect Dis       Date:  2007-03       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.